Drugs in Cardiopulmonary Resuscitation | Agenda Bookshop Skip to content
Selected Colleen Hoover Books at €9.99c | In-store & Online
Selected Colleen Hoover Books at €9.99c | In-store & Online
Age Group_Uncategorized
Age Group_Uncategorized
automatic-update
B01=Theodoros Xanthos
Category1=Non-Fiction
Category=MJD
COP=United States
Delivery_Delivery within 10-20 working days
Language_English
PA=Not available (reason unspecified)
Price_€100 and above
PS=Active
softlaunch

Drugs in Cardiopulmonary Resuscitation

English

Although approximately one million cardiac arrests occur every year in the USA and Europe, cardiac arrest remains a clinical condition still characterised by poor prognosis. One possible explanation may be the fact that although 70% of cardiac arrests take place in out-of-hospital settings, the majority of the victims do not receive basic life support (BLS) prior to the arrival of emergency medical services (EMS). Survival of out-of-hospital cardiac arrest victims strongly depends on prompt cardiopulmonary resuscitation (CPR). Survival rates will only improve, if delay time until initiation of CPR is kept to an absolute minimum. Good quality CPR, with an emphasis on chest compressions is a key component for the victims'' survival. Drugs play a secondary role in the treatment of these patients. This book presents the latest research in drug therapy in CPR. See more
Current price €239.39
Original price €251.99
Save 5%
Age Group_Uncategorizedautomatic-updateB01=Theodoros XanthosCategory1=Non-FictionCategory=MJDCOP=United StatesDelivery_Delivery within 10-20 working daysLanguage_EnglishPA=Not available (reason unspecified)Price_€100 and abovePS=Activesoftlaunch
Delivery/Collection within 10-20 working days
Product Details
  • Weight: 714g
  • Dimensions: 260 x 180mm
  • Publication Date: 17 Jun 2011
  • Publisher: Nova Science Publishers Inc
  • Publication City/Country: United States
  • Language: English
  • ISBN13: 9781611225129
We use cookies to ensure that we give you the best experience on our website. If you continue we'll assume that you are understand this. Learn more
Accept